T1	CHEM 12 22	irbesartán
#1	AnnotatorNotes T1	C0288171; irbesartan; Organic Chemical · Pharmacologic Substance
T2	ANAT 36 41	renal
#2	AnnotatorNotes T2	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T3	DISO 447 450	GNC
#3	AnnotatorNotes T3	C0152451; Chronic glomerulonephritis; Disease or Syndrome
T4	DISO 1407 1419	intolerancia
#4	AnnotatorNotes T4	C0277585; Intolerance to drug; Pathologic Function
T5	PROC 74 130	estudio clínico aleatorizado, prospectivo, de dos brazos
T6	DISO 58 67	diabética
#5	AnnotatorNotes T6	C0011849; Diabetes Mellitus; Disease or Syndrome | C0241863; Diabetic; Finding | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T7	PROC 210 221	tratamiento
#6	AnnotatorNotes T7	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T8	PROC 1222 1229	tratado
#7	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T9	CHEM 279 289	irbesartán
#8	AnnotatorNotes T9	C0288171; irbesartan; Organic Chemical · Pharmacologic Substance
T10	DISO 308 333	glomerulonefritis crónica
#9	AnnotatorNotes T10	C0152451; Chronic glomerulonephritis; Disease or Syndrome
T11	CHEM 358 408	inhibidores del enzima convertidor de angiotensina
#10	AnnotatorNotes T11	C0003015; Angiotensin-Converting Enzyme Inhibitors; Pharmacologic Substance
T12	CHEM 410 414	IECA
#11	AnnotatorNotes T12	C0003015; Angiotensin-Converting Enzyme Inhibitors; Pharmacologic Substance
T13	PROC 451 464	diagnosticada
#12	AnnotatorNotes T13	C0011900; Diagnosis; Diagnostic Procedure
T14	PROC 474 487	biopsia renal
#13	AnnotatorNotes T14	C0194073; Kidney biopsy; Diagnostic Procedure
T15	DISO 490 501	proteinuria
#14	AnnotatorNotes T15	C0033687; Proteinuria; Finding
T16	PROC 577 588	tratamiento
#15	AnnotatorNotes T16	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T17	CHEM 634 644	irbesartán
#16	AnnotatorNotes T17	C0288171; irbesartan; Organic Chemical · Pharmacologic Substance
T18	CHEM 666 670	IECA
#17	AnnotatorNotes T18	C0003015; Angiotensin-Converting Enzyme Inhibitors; Pharmacologic Substance
T19	DISO 750 761	proteinuria
#18	AnnotatorNotes T19	C0033687; Proteinuria; Finding
T20	PROC 866 877	seguimiento
#19	AnnotatorNotes T20	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T21	PROC 1070 1087	control tensional
T22	PROC 1161 1180	filtrado glomerular
#20	AnnotatorNotes T22	C0017654; Glomerular Filtration Rate; Diagnostic procedure
T23	CHEM 1326 1336	irbesartán
#21	AnnotatorNotes T23	C0288171; irbesartan; Organic Chemical · Pharmacologic Substance
T24	CHEM 1392 1396	IECA
#22	AnnotatorNotes T24	C0003015; Angiotensin-Converting Enzyme Inhibitors; Pharmacologic Substance
T25	DISO 1421 1424	tos
#23	AnnotatorNotes T25	C0010200; Coughing; Sign or Symptom
T26	CHEM 1540 1544	IECA
#24	AnnotatorNotes T26	C0003015; Angiotensin-Converting Enzyme Inhibitors; Pharmacologic Substance
T27	DISO 1562 1587	glomerulonefritis crónica
#25	AnnotatorNotes T27	C0152451; Chronic glomerulonephritis; Disease or Syndrome
T28	DISO 26 54	patología renal proteinúrica
T29	CHEM 229 277	antagonista de los receptores de angiotensina II
#26	AnnotatorNotes T29	C0521942; Angiotensin II receptor antagonist; Pharmacologic Substance
T30	DISO 335 338	GNC
#27	AnnotatorNotes T30	C0152451; Chronic glomerulonephritis; Disease or Syndrome
T31	ANAT 482 487	renal
#28	AnnotatorNotes T31	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T32	ANAT 505 510	orina
#29	AnnotatorNotes T32	C0042036; Urine; Body Substance
T33	CHEM 1464 1474	irbesartán
#30	AnnotatorNotes T33	C0288171; irbesartan; Organic Chemical · Pharmacologic Substance
T34	PROC 1613 1627	administración
#31	AnnotatorNotes T34	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T35	Neg_cue 55 57	no
T36	LIVB 294 303	pacientes
#32	AnnotatorNotes T36	C0030705; Patients; Patient or Disabled Group
T37	Duration 326 333	crónica
#33	AnnotatorNotes T37	C0205191; chronic; Temporal Concept
T38	LIVB 433 442	pacientes
#34	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T40	Duration 514 522	24 horas
T42	Duration 597 614	al menos 24 meses
T43	Duration 812 825	el tercer mes
T44	Duration 845 862	los 12 y 24 meses
T50	LIVB 1356 1365	pacientes
#35	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	LIVB 1548 1557	pacientes
#36	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	Duration 1580 1587	crónica
#37	AnnotatorNotes T52	C0205191; chronic; Temporal Concept
T39	PROC 1379 1387	tratados
#38	AnnotatorNotes T39	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T41	PROC 505 522	orina de 24 horas
#39	AnnotatorNotes T41	C0201978; Creatinine measurement, 24 hour urine; Laboratory Procedure
T45	ANAT 1170 1180	glomerular
#40	AnnotatorNotes T45	C0022663; Kidney Glomerulus; Body Part, Organ, or Organ Component | C1284485; Entire glomerulus; Body Part, Organ, or Organ Component
A1	Assertion T6 Negated
T46	Neg_cue 1286 1289	sin
T47	CONC 1290 1300	diferencia
A2	Assertion T47 Negated
#41	AnnotatorNotes T47	C1705241; Delta (difference); Quantitative Concept
R1	Negation Arg1:T46 Arg2:T47	
R2	Negation Arg1:T35 Arg2:T6	
T48	Neg_cue 964 966	no
T49	CONC 981 992	diferencias
A3	Assertion T49 Negated
#42	AnnotatorNotes T49	C1705241; Delta (difference); Quantitative Concept
R3	Negation Arg1:T48 Arg2:T49	
T53	CONC 1046 1057	diferencias
A4	Assertion T53 Negated
#43	AnnotatorNotes T53	C1705241; Delta (difference); Quantitative Concept
T54	Neg_cue 1031 1033	No
R4	Negation Arg1:T54 Arg2:T53	
T55	Neg_cue 1093 1100	ninguno
T56	Observation 1134 1180	descenso significativo del filtrado glomerular
A5	Assertion T56 Negated
#44	AnnotatorNotes T56	C0853068; Glomerular filtration rate decreased; Finding
R5	Negation Arg1:T55 Arg2:T56	
T57	Observation 1 7	Efecto
#45	AnnotatorNotes T57	C1518681; Outcome of Therapy; Finding (?)
R6	Causes Arg1:T1 Arg2:T57	
R7	Location_of Arg1:T2 Arg2:T28	
R8	Overlap Arg1:T28 Arg2:T6	
T58	Observation 142 182	efecto antiproteinúrico y nefroprotector
R9	Causes Arg1:T29 Arg2:T58	
R10	Causes Arg1:T9 Arg2:T58	
R11	Has_Duration_or_Interval Arg1:T10 Arg2:T37	
R12	Has_Duration_or_Interval Arg1:T30 Arg2:T37	
R13	Causes Arg1:T12 Arg2:T58	
R14	Causes Arg1:T11 Arg2:T58	
R15	Experiences Arg1:T36 Arg2:T58	
R16	Experiences Arg1:T36 Arg2:T7	
R18	Experiences Arg1:T36 Arg2:T10	
R19	Experiences Arg1:T36 Arg2:T30	
R20	Experiences Arg1:T36 Arg2:T11	
R21	Experiences Arg1:T36 Arg2:T12	
R22	Used_for Arg1:T29 Arg2:T7	
R17	Used_for Arg1:T9 Arg2:T7	
R25	Experiences Arg1:T38 Arg2:T3	
R26	Experiences Arg1:T38 Arg2:T14	
R27	Location_of Arg1:T31 Arg2:T14	
R28	Experiences Arg1:T38 Arg2:T15	
R29	Has_Duration_or_Interval Arg1:T41 Arg2:T40	
R24	Used_for Arg1:T17 Arg2:T16	
R31	Used_for Arg1:T18 Arg2:T16	
R32	Has_Duration_or_Interval Arg1:T17 Arg2:T42	
R33	Has_Duration_or_Interval Arg1:T18 Arg2:T42	
R36	Has_Duration_or_Interval Arg1:T20 Arg2:T44	
T60	Quantifier_or_Qualifier 993 1007	significativas
A6	Assertion T60 Negated
#46	AnnotatorNotes T60	C0237881; Statistical Significance; Quantitative Concept
R39	Has_Quantifier_or_Qualifier Arg1:T49 Arg2:T60	
T61	Quantifier_or_Qualifier 1301 1314	significativa
A7	Assertion T61 Negated
#47	AnnotatorNotes T61	C0237881; Statistical Significance; Quantitative Concept
R40	Has_Quantifier_or_Qualifier Arg1:T47 Arg2:T61	
R41	Negation Arg1:T48 Arg2:T60	
R42	Negation Arg1:T46 Arg2:T61	
R43	Used_for Arg1:T23 Arg2:T8	
R44	Experiences Arg1:T50 Arg2:T8	
R45	Experiences Arg1:T50 Arg2:T39	
R46	Used_for Arg1:T24 Arg2:T39	
R47	Experiences Arg1:T50 Arg2:T4	
R48	Experiences Arg1:T50 Arg2:T25	
R49	Before Arg1:T39 Arg2:T4	
R50	Before Arg1:T39 Arg2:T25	
R51	Before Arg1:T8 Arg2:T56	
R52	Before Arg1:T39 Arg2:T56	
T62	Observation 1485 1525	efecto antiproteinúrico y nefroprotector
R53	Causes Arg1:T33 Arg2:T62	
R54	Causes Arg1:T26 Arg2:T62	
R55	Experiences Arg1:T51 Arg2:T33	
R56	Experiences Arg1:T51 Arg2:T62	
R57	Experiences Arg1:T51 Arg2:T26	
R58	Experiences Arg1:T51 Arg2:T27	
R59	Has_Duration_or_Interval Arg1:T27 Arg2:T52	
R60	Experiences Arg1:T51 Arg2:T34	
T63	CONC 708 717	reducción
#48	AnnotatorNotes T63	C0547047; Decrease; Quantitative Concept
R23	After Arg1:T63 Arg2:T44	
R35	After Arg1:T63 Arg2:T43	
R37	Overlap Arg1:T3 Arg2:T15	
R30	Before Arg1:T14 Arg2:T13	
R61	Before Arg1:T41 Arg2:T13	
T59	Result_or_Value 523 534	mayor a 1 g
R62	Has_Result_or_Value Arg1:T41 Arg2:T59	
T64	Quantifier_or_Qualifier 718 731	significativa
#49	AnnotatorNotes T64	C0237881; Statistical Significance; Quantitative Concept
R63	Has_Quantifier_or_Qualifier Arg1:T63 Arg2:T64	
#50	AnnotatorNotes T21	C0005824; Blood pressure determination; Health Care Activity (?) 
#51	AnnotatorNotes T28	C5677904; Proteinuric nephropathy; Finding
A8	Experiencer T36 Patient
A9	Experiencer T38 Patient
A10	Experiencer T50 Patient
A11	Experiencer T51 Patient
R34	Has_Result_or_Value Arg1:T22 Arg2:T56	
